- Home
- TOMZ vs ADAP Comparison
TOMZ vs ADAP Comparison
Compare TOMZ & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- ADAP
- Stock Information
- Founded
- TOMZ 1979
- ADAP 2008
- Country
- TOMZ United States
- ADAP United Kingdom
- Employees
- TOMZ N/A
- ADAP N/A
- Industry
- TOMZ Diversified Commercial Services
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- ADAP Health Care
- Exchange
- TOMZ Nasdaq
- ADAP Nasdaq
- Market Cap
- TOMZ 20.4M
- ADAP 21.3M
- IPO Year
- TOMZ N/A
- ADAP 2015
- Fundamental
- Price
- TOMZ $0.84
- ADAP $0.07
- Analyst Decision
- TOMZ Strong Buy
- ADAP Hold
- Analyst Count
- TOMZ 1
- ADAP 6
- Target Price
- TOMZ $3.50
- ADAP $1.02
- AVG Volume (30 Days)
- TOMZ 26.3K
- ADAP 63.5M
- Earning Date
- TOMZ 10-29-2025
- ADAP 11-12-2025
- Dividend Yield
- TOMZ N/A
- ADAP N/A
- EPS Growth
- TOMZ N/A
- ADAP N/A
- EPS
- TOMZ N/A
- ADAP N/A
- Revenue
- TOMZ $6,219,036.00
- ADAP $65,084,999.00
- Revenue This Year
- TOMZ $18.31
- ADAP N/A
- Revenue Next Year
- TOMZ $103.30
- ADAP $52.35
- P/E Ratio
- TOMZ N/A
- ADAP N/A
- Revenue Growth
- TOMZ N/A
- ADAP N/A
- 52 Week Low
- TOMZ $0.63
- ADAP $0.04
- 52 Week High
- TOMZ $1.50
- ADAP $1.12
- Technical
- Relative Strength Index (RSI)
- TOMZ 43.95
- ADAP 44.99
- Support Level
- TOMZ $0.82
- ADAP $0.06
- Resistance Level
- TOMZ $0.92
- ADAP $0.07
- Average True Range (ATR)
- TOMZ 0.05
- ADAP 0.01
- MACD
- TOMZ 0.00
- ADAP 0.01
- Stochastic Oscillator
- TOMZ 26.32
- ADAP 88.67
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.